発表論文（2001年以前）及び総説・単行書・教科書
2001
1. Songkram, C.; Takaishi, K.; Yamaguchi, K.; Kagechika, H.; Endo, Y.*
Structures of Bis- and Tris(2-phenyl-o-carboran-1-yl)benzenes. Construction of Three-dimensional Structures Converted from Planar Arylacetylenic Arrays
Tetrahedron Lett., 2001, 42, 6365-6368.
2. Endo, Y.*; Taoda, Y.,
Electronic Effects of Icosahedral Carboranes: Kinetic Evidence for Interaction between Boron Atom and Nucleophile on the Solvolysis of (o-Carboranyl)benzyl Tosylates.
Tetrahedron Lett., 2001, 42, 6327-6331.
3. Yamamoto, K.; Endo, Y.*
Utility of Boron Clusters for Drug Design. Hansch-Fujita Hydrophobic Parameters p of Dicarba-closo-dodecaboranyl Groups.
BioMed. Chem. Lett., 2001, 11, 2389-2392.
4. Songkram, C.; Yamasaki, R.; Takaishi, K.; Yamaguchi, K.; Kagechika, H.; Endo, Y.*
Molecular Construction Based on Icosahedral Carboranes and Aromatic Urea Groups. A New Type of Carboracycles.
Tetrahedron Lett., 2001, 42, 5913-5916.
5. Sou, S.; Takahashi, H.; Yamasaki, R.; Kagechika, H.; Endo, Y.; Hashimoto, Y.,
a-Glucosidase Inhibitors with 4,5,6,7-Tetrachlorophtalimide Skeleton with a Cycloalkyl or Dicarba-closo-dodecaborane.
Chem. Pharm. Bull., 2001, 49, 791-793.
6. Endo, Y.*; Iijima, T.; Yamakoshi, Y., Fukasawa, H.; Miyaura, C.; Inada, M.; Kubo, A.; Itai, A.
Potent Estrogen Agonists Based on Carborane as a Hydrophobic Skeletal Structure. A New Medicinal Application of Boron Clusters.
Chemistry and
Biology, 2001,
8, 341-355.
7. Endo, Y.*; Iijima, T.; Yaguchi, K.; Kawachi, E.; Kagechika, H.,
Medicinal Application of Dicarba-closo-dodecaboranes. Relation between Retinoidal Activity and Conformation of Two Aromatic Nuclei.
BioMed. Chem. Lett., 2001, 11, 1307-1311.
2000
8. Fukasawa, H.; Yamaguchi, M.; Hashimoto, Y.; Endo, Y.; Shudo, K.
Enhancing Effect of Tumor Promoters, Phorbol Esters and Teleocidins, on Nuclear Receptor-mediated Transcription.
Biol. Pharm. Bull., 2000, 23, 1414-1417.
9. Songkram, C.; Tanatani, A.; Yamasaki, R.; Yamaguchi, K.; Kagechika, H.; Endo, Y*.,
Structures of N, N’-Bis(1,2-dicarba-closo-dodecaboran-1-yl)phenylureas. Building Blocks for Carborane Containing Macromolecules.
Tetrahedron Lett., 2000, 41, 7065-7070.
10. Mayumi, S.; Azuma, A.; Kobayashi, H.; Sodeoka, M.; Yano, K.; Sugimoto, S.; Endo, Y.; Hashimoto, Y.
Identification of Protein Disulfide Isomerase as a Phorbol
ester-binding Protein.
Biol. Pharm.Bull., 2000, 23, 1111-1113.
11. Endo, Y.*; Yaguchi, K.; Kawachi, E.; Kagechika, H.,
Polymethylcarborane as a Novel
Bioactive Moiety: derivatives with Potent Retinoid Antagonistic Activity.
BioMed. Chem. Lett., 2000, 10, 1733-1736.
12. Tsuji, M.; Koiso, Y.; Takahashi, H; Hashimoto, Y.; Endo, Y.
Modulators of Tumor Necrosis Factor a Production Bearing Dicarba-closo-dodecaborane as a Hydrophobic Pharmacophore.
Biol. Pharm. Bull., 2000, 23, 513-516.
13. Endo, Y.*; Sawabe, T., Taoda, Y.
Electronic Effects of Dicarba-closo-dodecaboranes. Retentive Solvolysis of (1,2-Dicarba-closo-dodeca-boran-1yl)benzyl p-Toluenesulfonates.
J. Am. Chem. Soc., 2000, 122, 180-181.
14. Endo, Y.*; Yoshimi, T.; Yamakoshi, Y.
New Estrogen Antagonists Bearing Dicarba-closo-dodecaborane as a Hydrophobic Pharmacophore.
Chem. Pharm. Bull. 2000, 48, 312-314.
15.
Yamakoshi, Y.; Otani,
Y.; Fujii, S.; Endo, Y.*
Dependence of Estrogenic Activity
on the Shape of the 4-Alkyl Substituent in Simple Phenols.
Biol. Pharm. Bull., 2000, 23, 259-261.
16. Endo, Y.*; Uchida, T.; Yamaguchi, K.
Anioic [3,3]Rearrangements of Cyclic Hydrazine Diacylates to Medium-size Cyclic Diamides..
Heterocycles, 2000, 53, 151-158.
17.
Endo, Y.*; Yokoyama, A.
A. Role of the Hydrophobic Moiety
of Protein Kinase C Modulators. Synthesis and Activity of 2-Alkylated
Benzolactams
BioMed. Chem. Lett., 2000, 10, 63-66.
1999以前
18. Endo, Y.*; Yoshimi, T.; Iijima, T.; Yamakoshi, Y.
Estrogen Antagonists Bearing Dicarba-closo-dodecaborane as a Hydrophobic Pharmacophore.
BioMed. Chem. Lett., 1999, 9, 3387-3392.
19.
Endo, Y.*; Iijima, T.; Yamakoshi, Y., Kubo, A.; Itai, A.
Structure-activity Study of
Estrogenic Agonists Bearing Dicarba-closo-dodecaborane.
Effect of Geometry and Separation Distance of Hydroxyl Groups at the Ends of
Molecules.
BioMed. Chem. Lett., 1999, 9, 3313-3318.
20. Endo, Y.*; Taoda, Y.
Electronic Effects of Dicarba-closo-dodecaboranes. Friedel-Crafts Acylation of 1-Phenyl-closo-dodecaboranes.
Tetrahedron Lett, 1999, 40, 9073-9076.
21. Yaguchi, K.; Endo, Y.*
Steric Effects of Polymethyl-dicarba-closo- dodecaboranes. Unusual Reactivity of N-(Deca-B-methyl-1,12-dicarba-closo-dodecaboran-1-carbonyl)pyridinium.
Tetrahedron Lett., 1999, 40, 7351-7354.
22. Endo, Y.*; Yoshimi, T.; Kimura, K.; Itai, A.
Protein Kinase C Modulators Bearing Dicarba-closo-dodecaborane as a Hydrophobic Pharmacophore.
BioMed. Chem. Lett., 1999, 9, 2561-2564.
23. Endo, Y.*; Iijima, T.; Yamakoshi, Y.; Yamaguchi, M.; Fukasawa, H.; Shudo, K.
Potent Estrogen Agonists Bearing Dicarba-closo-dodecaborane As a Hydrophobic Pharmacophore.
J. Med. Chem., 1999, 42, 1501-1504.
24. Endo, Y.*; Yaguchi, K.; Tsuji, M.; Shudo, K.
Functionalization of Polymethylcarboranes. Preparation and Reactivity of Daca-B-methyl-1,12-dicarba-closo-dodecaborane-1-carboxylic Acid.
Chem. Pharm. Bull., 1999, 47, 699-701.
25. Endo, Y.*; Iijima, T.; Ohta, K.; Kagechika, H.; Kawachi, E.; Shudo, K.
Dicarba-closo-dodecaboranes as a Pharmacophore. Nonel Potent Retinoidal Agonistis.
Chem. Pharm. Bull., 1999, 47, 585-587.
26. Iijima, T.; Endo, Y.*; Tsuji, M.; Kawachi, E.; Kagechika, H.; Shudo, K.
Dicarba-closo-dodecaboranes as a Pharmacophore. Retinoidal Antagonists and Potential Agonists.
Chem. Pharm. Bull., 1999, 47, 398-404.
27. Kimura, K.; Mizutani, M. Y.; Tomioka, N.; Endo, Y.; Shudo, K.; Itai, A.
Docking Study of Bryostatins to Protein Kinase Cd Cys2 Domain.
Chem Pharm. Bull., 1999, 47, 1134-1137.
28. Endo, Y.*; Shimazu, M.; Fukasawa, H.; Driedger, P. E.; Kimura, K.; Tomioka, N.; Itai, A.; Shudo, K.
Synthesis, Computer Modeling and Biological Evaluation of Novel Protein Kinase C Aginists Based on a 7-Membered Lactam Moiety.
BioMed. Chem. Lett., 1999, 9, 173-178.
29. Endo, Y.*; Takehana, S.; Ohno, M.; Driedger, P. E.; Stabel, S.; Mizutani, M.; Tomioka, N.; Itai, A.; Shudo, K.
Clarification of the Binding Mode of Teleocidin and Benzolactams to the Cys2 Domain of Protein Kinase Cd by Synthesis of Hydrophobically Modified, Teleocidin-mimicking Benzolactams and Computational Docking Simulation.
J. Med. Chem., 1998, 41, 1476-1496.
30. Okabe, S.; Sueoka, N.; Komori, A.; Suganuma, M.; Endo, Y.; Shudo, K.; Fujiki, H.
Twist form of Teleocidin Derivatives is Active in in vivo Tumor Promotion by (-)-Benzolactam-V8-310.
Biol. Pharm. Bull., 1998, 21, 465-468.
31. Endo, Y.*; Hirano, M.; Driedger, P. E.; Stabel, S.; Shudo, K.
A Novel Conformational Constrained Analogues of Diacylglycerol. Protein Kinase C Affinity of Simplified Compounds Based on 6-Membered Lactam Moiety.
BioMed. Chem. Lett., 1997, 7, 2997-3000.
32. Yamaguchi, M.; Endo, Y.*; Shimizu, M.; Yamamoto, K.; Yamada, S.; Shudo, K.
3b,5a-Dihydroxycholestan-6-one Exists in Human Blood.
Biol. Pharm. Bull., 1997, 20, 1044-1046.
33. Endo, Y.*; Uchida, T.; Shudo, K.
Anionic [3,3], [2,3] and [1,2]Rearrangements of Aliphatic and Aromatic Acyl Hydrazines with N-N Bond Cleavage.
Tetrahedron Lett., 1997, 38, 2113-2116.
34. Endo, Y.*; Ohno, M.; Takehana, S.; Driedger, P. E.; Stabel, S.; Shudo, K.
Role of the Hydrophobic Moiety of Tumor Promoters. Synthesis and Activity of Benzolactams with Alkyl Substituents at Various Positions.
Chem. Pharm. Bull., 1997, 45, 424-426.
35. Azuma, A.; Hashimoto, Y.; Yamaguchi, M.; Takehana, S.; Ando, Y.; Iwasaki, S.; Fukasawa, H.; Endo, Y.; Shudo, K.
Photoaffinity Labeling and Affinity Sorbent Gels of Tumor Promoter-Binding Protein (CN-TPBP).
Biol. Pharm. Bull., 1997, 20, 5-8.
36. Shimazu, M.; Endo, Y.*; Shudo, K.
Reactivity of 1,3-Di-t-butylaziridinones with Phenyl Substituents. A New Fragmentation of a-Lactam.
Heterocycles, 1997, 735-744.
37. Itai, A.; Matsuo, A.; Mizutani, M.; Tomioka, N.; Endo, Y.; Shudo, K.
Advanced Docking of Two Teleocidin Congeners with the cys2 Domain of Protein Kinase Cd.
Chem. Pharm. Bull., 1997, 45, 573-575.
38. Endo, Y.*; Ohno, M.; Hirano, M.; Itai, A.; Shudo, K.
Synthesis, Conformation and Biological Activity of Teleocidin Mimics, Benzolactams. A Clarification of the Conformatioal Flexibility Problem in Structure-activity Studies of Teleocidins.
J. Am. Chem. Soc., 1996, 118, 1841-1855.
39. Endo, Y.*; Yamaguchi, M.; Hirano, M.; Shudo, K.
Role of the Hydrophobic Moiety of Tumor Promoters. Synthesis and Activity of 9-Alkylated Benzolactams.
Chem. Pharm. Bull., 1996, 44, 1138-1140.
40. Matsushima, Y.; Fukasawa, H.; Endo, Y.; Hashimoto, Y.; Shudo K.
Enhancement of Human Papillomavirus Type 18 Gene Expression in Hela Cells by 12-O-Tetradecanoylphorbol-13-acetate, 3b,5a-Dihydroxycholestan- 6-one, and Cholesterol.
Biol. Pharm. Bull., 1994, 17: 1292-1295.
41. Endo, Y.*; Imada, T.; Yamaguchi, K.; Shudo, K.
Conformational States of Indolactams. Structures of 13-N-Desmethylindolactam-V and 13-O-Indolactam-V.
Heterocycles, 1994, 39: 571-579.
42. Endo, Y.*; Ohno, M.; Hirano, M.; Fujiwara, T.; Sato, A.; Hinuma, Y.; Shudo, K.
Teleocidins and Benzolactams Inhibit Cell Killing by Human Immunodeficiency Virus Type 1 (HIV-1).
Biol. Pharm. Bull., 1994, 17: 1147-1149.
43. Endo, Y.*; Hashimoto, Y.; Fukasawa, H.; Shudo, K.
Synthesis of Oxygenated Cholesterols as Structural Mimics of Phorbol Ester-type Tumor Promoters.
Chem. Pharm. Bull., 1994, 42, 462-469.
44. Endo, Y.*; Ohno, M.; Hirano, M.; Takeda, M.; Itai, A.; Shudo, K.
Chiral Requirement for the Tumor Promoters. Conformationand Activity Study of Benzolactams.
BioMed. Chem. Lett., 1994, 4, 491-494.
45. Endo, Y.*; Uchida, T.; Hizatate, S.; Shudo, K.
Anionic Hetero [3,3]- and [3,5]Rearrangements of Hydroxylamine Derivatives Accompanied with N-O Bond Cleavage.
Synthesis, 1994, 1096-1105.
46. Endo, Y.*; Uchida, T.; Hizatate, S.; Shudo, K.
Anionic Hetero[3,3] rearrangements of N,O-Diacylhydroxyl- amines to Succinic Acid Derivatives.
Chem. Pharm. Bull., 1994, 42, 419-421.
47. Ohno, M.; Endo, Y.*; Hirano, M.; Itai, A.; Shudo, K.
Designed Molecules Reproducing the Two Conformations of Teleocidins.
Tetrahedron Lett., 1993, 34, 8119-8122.
48. Kawai, T.; Endo, Y.; Yamaguchi, K.; Shudo, K.; Itai, A.
A Crystal Structures of Two Indolactams.
Acta Crystall. 1993, B49: 769-773.
49. Endo, Y.; Hashimoto, Y.; Fukasawa, H.; Shudo, K.
Oxygeneted Steroids as Ligands for Cytosolic-nuclear Tumor Promoter Binding Protein (CN-TPBP).
Biochem. Biophys. Res. Commun., 1993, 193: 1529-1534.
50. Nagata, R.; Endo, Y.*; Shudo, K.
Photocyclization of g-Chlorotiglyl-L-tryptophan Methyl Ester Yields Azocinoindole and Azepinoindole derivatives.
Chem. Pharm. Bull., 1993, 41, 369-372.
51. Paquette, L. A.; Deaton, D. N.; Endo, Y.; Poupart, M-A.
Studies Directed toward the Total Synthesis of Cerorubenic Acid-III. 3. A Convergent Enantioselective Approach Involving New Arrangements for Actuation of Ring D Cyclization.
J. Org. Chem., 1993, 58: 4262-4273.
52. Kawai, T.; Ichinose, T.; Takeda, M.; Tomioka, N.; Endo, Y.; Yamaguchi, K.; Shudo, K.; Itai,A.
Prediction of Ring Conformations of Indolactams. Crystal and Solution Structures.
J. Org. Chem., 1992, 57, 6150-6155.
53. Kawai, T.; Ichinose, T.; Endo, Y.; Shudo, K.; Itai, A.
Active Conformation of a Tumor Promoter, Teleocidin. A Molecular Dynamic Study.
J. Med. Chem., 1992, 35, 2248-2253.
54. Endo, Y.*; Kataoka, K.; Haga, N.; Shudo, K.
Acid-Catalyzed Rearrangement of O-(2-Arylphenyl)hydroxylamines to Aryldihydro-azepinones.
Tetrahedron Lett., 1992, 33, 3339-3342.
55. Haga, N.; Endo, Y.*; Kataoka, K.; Yamaguchi, K.; Shudo, K.
Acid-Catalyzed Amino-Migration of O-Phenylhydroxylamines.
J. Am. Chem. Soc., 1992, 114, 9795-9806.
56. Endo, Y.*; Shudo, K.
Anionic Hetero[3,3]rearrangements. N-Acyl-N'-enyl-hydrazines to Pyrrolidinines.
Heterocycles, 1992, 33, 91-95.
57. Endo, Y*.; Hizatate, S.; Shudo, K.
Anionic Hetero[3,3]rearrangements. N-Acylhydroxyl-amine-O-carbamates to a-Amino Acids. A New Method for Introduction of Amino Groups at the a-Position of Carboxylic Acids.
Synlett, 1991, 649-651.
58. Endo, Y.*; Shudo, K.
Anionic 3,4-Diaza[3,3]sigmatropic rearrangements of N,N- Diacyl-hydrazines.
Tetrahedron Lett., 1991, 32: 4517-4520.
59. Endo, Y.*; Hizatate, S.; Shudo, K.
Anionic [3,3]Rearrangement of N-Phenyl-O-acylhydroxyl-amines to o-Aminophenylacetic Acids.
Tetrahedron Lett., 1991, 32: 2803-2806.
60. Itai, A.; Kato, Y.; Tomioka, N.; Iitaka, Y.; Endo, Y.; Hasegawa, M.; Shudo, K., Fujiki, H.; Sakai, S.
A Receptor Model for Tumor Promoters: Rational Superposition of Teleocidins and Phorbol Esters.
Proc. Natl. Acad. Sci. USA., 1988, 85: 3688-3692.
61. Hirota, M.; Suttajit, M.; Endo, Y.; Shudo, K.; Wongchai, V.; Hecker, E.; Fujiki, H.
A New Promoter from the Seed Oil of Jatropha Curcas L., An Intramolecular Diester of 12-Deoxy-16-hydroxyphorbol.
Cancer Res., 1988, 48: 5800-5804.
62. Hashimoto, Y.; Endo, Y.; Shudo, K.;
Aramaki, Y.; Nakajima, T.
Synthesis of Spider Toxin and its derivatives.
Pept. Chem. 1988, 363-366.
63. Shudo, K.; Endo, Y.; Aramaki, Y.; Kawai, N.; Nakajima, T.
Newly Synthesized Analogues of the Spider Toxin Block the Crustacean Glutamate Receptor.
Neurosci. Res., 1987, 5: 82-85.
64. Hirota, M.; Suganuma, M.; Yishizawa, S.; Horiuchi, T.; Nakayasu, M.; Hasegawa, M.; Endo, Y.; Shudo, K.; Fujiki, H.
Synthetic Analogues (Indolactams) of Indolactam-V Are New Congeners of the Teleocidin Class Tumor Promoters.
Jpn. J. Cancer Res. (Gann), 1987, 78: 577-582.
65. Endo, Y.; Hasegawa, M.; Itai, A.; Shudo, K.
Synthesis and Stereochemistry of Indolactam Congeners. Conformational Behavior of the Nine-membered Lactams.
Tetrahedron, 1987, 43: 3695-3704.
66. Hashimoto, Y.; Endo, Y.; Shudo, K.; Aramaki, Y.; Nakajima, T.; Kawai, N.
Synthesis of Spider Toxin (JSTX-3) and Its Analogs.
Tetrahedron Lett., 1987, 28: 3511-3514.
67. Endo, Y.; Sato, Y.; Shudo K.
Synthesis of 7-Substituted Indolactam-V. An Introduction of Hydrophobic Moeties on the Indole Ring.
Tetrahedron, 1987, 43: 2241-2247.
68. Sakai, S.; Hitotsuyanagi, Y.; Yamaguchi, K.; Aimi, N.; Ogata, K.; Kuramochi, T.; Seki, H.; Hara, R.; Fujiki, H.; Suganuma, M.; Sugimura, T.; Endo, Y.; Shudo, K.; Koyama, Y.
The Structures of Additional Teleocidin Class of Tumor Promoters.
Chem. Pharm. Bull., 1986, 34: 4883-4886.
69. Sakai, S.; Hitotsuyanagi, Y.; Aimi, N.; Fujiki, H.; Suganuma, M.; Sugimura, T.; Endo, Y.; Shudo, K.
Absolute Configuration of Lyngbyatoxin A (Teleocidin A-1) and Teleocidin A-2.
Tetrahedron Lett., 1986, 27: 5219-5220.
70. Endo, Y.; Shudo, K.; Itai, A.; Hasegawa, M.; Sakai, S.
Synthesis and Stereochemistry of Indolactam-V, an Active Fragment of Teleocidins. Structural Requirement for Tumor-promoting Activity.
Tetrahedron, 1986, 42: 5905-5924.
71. Ninomiya, M.; Fujiki, H.; Paik, N. S.; Hakii, H.; Suganuma, M.; Hitotsuyanagi, Y.; Aimi, N.; Sakai, S.; Endo, Y.; Shudo, K., Sugimura, T.
Des-O-methylolivoretin C Is a New Memberof the Teleocidin Class of Tumor Promoters.
Jpn. J. Cancer
Res. (Gann), 1986,
77:
222-225.
72. Endo, Y.; Nanikawa, K.; Shudo, K.
Chemistry of O-Arylhydroxylamines. A Novel Acid-catalyzed Rearrangement of O-Aryl-N-acetoacetylhydroxylamines to Benzofuranes.
Tetrahedron Lett., 1986, 27: 4209-4212.
73. Endo, Y.; Hasegawa, M.; Itai, A.; Shudo, K.; Tori, M.; Asakawa, Y.; Sakai, S.
Tumor promoters Exist in Two Conformational States in Solution. Stereochemistry of Indolactam-V.
Tetrahedron Lett., 1985, 26: 1069-1072.
74. Fujiki, H.; Suganuma, M.; Hakii, H.; Nakayasu, M.; Endo, Y.; Shudo, K.; Irie, K.; Koshimizu, K.; Sugimura, T.
Tumor Promoting activities of New Synthetic Analogues of Teleocidin.
Pro. Japan. Acad.(B), 1985, 61: 45-48.
75. Hitotsuyanagi, Y.; Fujiki, H.; Suganuma, M.; Aimi, N.; Sakai, S.; Endo, Y.; Shudo, K.; Sugimura, T.
Isolation and Structure Elucidation of Teleocidin B-1, B-2, B-3 and B-4.
Chem. Pharm. Bull., 1984, 32: 4233-4236.
76. Hitotsuyanagi, Y.; Yamaguchi, K.; Ogata, K.; Aimi, N.; Sakai, S.; Koyama, Y.; Endo, Y.; Shudo, K.; Itai, A.; Iitaka, Y.
Elucidation of the Structures of Olivoretin B and C.
Chem. Pharm. Bull., 1984, 32: 3774-3778.
77. Horiuchi, T.; Fujiki, H.; Suganuma, M.; Hakii, H.; Nakayasu, M.; Hitotsuyanagi, Y.; Aimi, N.; Sakai, S.; Endo, Y.; Shudo, K.; Sugimura, T.
Studies on Olivoretins Indicate a Requirment for a Free Hydroxyl Group for Teleocidin B Activity.
Jpn. J. Cancer Res. (Gann), 1984, 75: 837-840.
78. Fujiki, H.; Suganuma, M.; Nakayasu, M.; Tahira, T.; Endo, Y.; Shudo, K.; Sugimura, T.
Structure Activity Studies on Synthetic Analogues (Indolactams) of the Tumor Promoter Teleocidin.
Jpn. J. Cancer Res. (Gann), 1984, 75: 866-870.
79. Endo, Y.; Shudo, K.; Furuhata, K.; Ogura, H.; Sakai, S.; Aimi, N.; Hitotsuyanagi, Y.; Koyama, Y.
Synthesis of Optically Active Teleocidin Derivatives. Absolute Configuration of Teleocidin B and Olivoretin A.
Chem. Pharm. Bull., 1984, 32: 358-361.
80. Endo, Y.; Terashima, T.; Shudo, K.
A Novel Acid-catalyzed Rearrangement of N-Aryl-N'-aryloxyureas to Biphenyl Derivatives. A [5,5]Rearrangement Involving Three Heteroatoms.
Tetrahedron Lett., 1984, 25: 5537-5540.
81. Iijima, H.; Endo, Y.; Shudo, K.; Okamoto, T.
Phenoxenium Ions. Identical Intermediates in the Acid-catalyzed Solvolysis of N-Tosyl-O-arylhydroxylamines and in the Thermolysis of N-aryloxypyridinium Salts.
Tetrahedron, 1984, 40: 4981-4985.
82. Endo, Y.; Shudo, K.; Okamoto, T.
An Acid Catalyzed Rearrangement of N-Alkyl-N'-phenoxyureas; Synthesis of 2-Alkylaminophenols from Phenols.
Synthesis, 1983, 471-473.
83. Endo, Y.; Shudo, K.; Okamoto, T.
Formation of Punmerer's Ketone from 4-Methylphenoxenium Ion. An Acid-catalyzed Solvolysis of N-p-Toluenesulfonyl-O-(4-tolyl)hydroxylamine in p-Cresol.
Chem. Pharm. Bull., 1983, 31: 3769-3770.
84. Endo, Y.; Shudo, K.; Okamoto, T.
Molecular Requirements for epigenetic Modulators. Synthesis of Active Fragment of Teleocidins and Lyngbyatoxin.
Chem. Pharm. Bull., 1982, 30: 3457-3460.
85. Endo, Y.; Shudo, K.; Okamoto, T.
An Acid-catalyzed Solvolysis of N-Sulfonyl- and N-Acylhydroxylamines; Phenoxenium Ions.
J. Am. Chem. Soc., 1982, 104: 6393-6397.
86. Endo, Y.; Shudo, K.; Okamoto, T.
Reaction of Benzene with Diphenylsulfoxides.
Chem. Pharm. Bull., 1981, 29: 3753-3755.
87. Endo, Y.; Shudo, K.; Okamoto, T.
An Acid Catalyzed Rearrangement of O-Aryl-N-benzoylhydroxylamines: Synthesis of Catechols from Phenols.
Synthesis, 1980, 461-463.
88. Ohta, T.; Machida, R.; Takeda, K.; Endo, Y.; Shudo, K.; Okamoto, T.
Reductive Phenylation of Nitroarenes.
J. Am. Chem. Soc., 1980, 102: 6385-6386.
89. Endo , Y.; Shudo, K.; Okamoto, T.
A Novel Phenol-benzene Coupling Reaction. An Acid-catalyzed Reaction of N-Acyl-O-arylhydroxylamines with Benzene.
J. Am. Chem. Soc., 1977, 99: 7721-7723.
90. Endo, Y.; Ohta, T.; Shudo, K.; Okamoto, T.
Reaction of Arylhydroxamic Acids with Benzene.
Heterocycles, 1977, 8: 367-370.
91. Shudo, K.; Ohta, T.; Endo, Y.; Okamoto, T.
Phenylation of N,N-Dialkylaniline-N-oxides.
Tetrahedron
Lett., 1977,
18: 105-108.
総説
92. 太田公規：超分子化学を利用した創薬：麻酔剤の使用法に革命を起こすホスト化合物
ファルマシア 2013, 49, 444
93. 太田公規, 遠藤泰之：ホウ素クラスターを用いた実践的創薬研究
ファルマシア 2012, 48, 504-508.
94. 遠藤泰之, 太田公規: ホウ素クラスター：カルボランの有機化学―合成、構造、立体分子構築への応用
有機合成化学協会誌, 2007, 65: 320-333.
95. 遠藤泰之：ホウ素クラスターの医薬化学の医薬化学への応用
東北薬科大学研究誌, 2003, 50: 1-16.
96. 遠藤 泰之: ホウ素クラスターの医薬化学への応用：カルボラン骨格を有するエストロゲン受容体リガンド、
MEDCHEM NEWS (DISCOVERY), 2000, 10: No 3. 20-24.
97. 遠藤 泰之: 含ホウ素クラスターの医薬化学、
現代化学, 1999, 342: 51-58.
98. 遠藤 泰之: 発がんプロモーターの活性立体構造の解析、
RADIOISOTOPES, 1996, 45: 95-104.
99. 遠藤 泰之、大野 道博、首藤 紘一: テレオシジンの活性立体配座：新規活性分子のデザインと合成、
薬学雑誌、総説（総合論文）1994, 114: 464-477.
100.遠藤 泰之、首藤 紘一: フェノキセニウムイオンの生成と反応、
薬学雑誌、総説（総合論文）1994, 114: 565-576.
101.遠藤 泰之: 発癌プロモーター、テレオシジンの合成と生物活性、
有機合成化学協会誌、1988, 46: 344-355.
102.遠藤 泰之: Teleocidin を含むTPAタイプのプロモーターの活性構造の解析、
日本農芸化学会誌、1987, 61: 834-837.
103.遠藤 泰之、板井 昭子、首藤 紘一、藤木 博太: 発がんプロモーターの活性構造、
癌と化学療法、1986, 13: 3365-3375.
104.藤木 博太、菅沼 雅美、遠藤 泰之、首藤 紘一ら: TPAタイプおよび non-TPAタイプ発癌プロモーターの活性と作用機構、
癌と化学療法、1986, 13: 758-765.
単行書
105.Endo, Y. Carboranes as Hydrophobic Pharmacophores: Applications for Design of Nuclear Receptor Ligands “Boron-Based Compounds: Potential and Emerging Applications in Medicine”, Evamarie Hey-Hawkins, E., Vinas, C. (eds.), Wiley-VHC, Weinheim, pp3-19, 2018.
106.Endo, Y.; Yoshimi, T.; Miyaura, C: Utility of Boron Cluster for Drug Design: Selective Estrogen Receptor Modulators (SERMs) Bearing Carborane As a Hydrophobic Skeletal Structure., “Boron Chemistry at the Beginning of the 21th century”, Bubnov, Yu., et al (eds.), Russian Academy of Sciences, Nauka, Moscow, pp298-306, 2003.
107.Gabel, D.; Endo, Y.: Polyboranes in Medicinal Chemistry. “Molecular Clusters of the Main-Group Elements”, Driess, M.; Noth, H (eds.), Wiley-VHC, Weinheim, 2003.
108.遠藤泰之: 受容体の構造と細胞内情報伝達（訳）, “オックスフォード・メディシナルケミストリー”, 北川勲、柴崎正勝、富岡清 監訳 (p91-118) 丸善（東京）, 2003.
109.Endo, Y*.: A New Medicinal Application of Boron Clusters. Potent Nuclear Receptor Ligands Bearing Carborane as a Hydrophobic Pharmacophore.
“Contemporary Boron Chemistry”, Wade, K., et al (eds.), the Royal Society of Chemistry, Cambridge Science Press, Cambridge, pp139-143, 2000.
110.遠藤 泰之*: 発癌プロモーター、テレオシジンの化学と生物活性,
発癌と制癌の化学（p83-114) 廣川書店（東京）, 1990.
111.Fujiki, H., Suganuma, M., Tahira, T., Yoshioka, A., Nakayasu, M., Endo, Y., Shudo, K., Takayama, S., Moore, R. E., Sugimura, T.: New Classes of Tumor Promoters: Teleocidin, Aplysiatoxin and Palytoxin.,
"Cellular Interactions by Environmental Tumor promoters" Fujiki,H., et al (eds.), Japan Sci. Soc. Press, Tokyo/ VNU Science Press, Utrecht, pp37-45, 1984.
教科書
112.遠藤泰之、スタンダード薬学シリーズⅡ 化学系薬学 II 生体分子・医薬品の化学による理解（日本薬学会編）東京化学同人（東京）2016, p186-191, 6/ 337
113.遠藤泰之、スタンダード薬学シリーズ 化学系薬学 I 化学物質の性質と反応（日本薬学会編）東京化学同人（東京）2015, p360-369, 10/ 437
114.遠藤泰之、スタンダード薬学シリーズ 化学系薬学 IV 演習編（日本薬学会編）東京化学同人（東京）2008, p107-112, p116-117, 8/204
115.遠藤泰之、ベーシック薬学教科書シリーズ 創薬科学・医薬化学、（橘高敦史編）
化学同人（京都） 2007, p165-216, 52/297
116.遠藤泰之、知っておきたい有機反応100（日本薬学会編）
東京化学同人（東京）2006, p47-62, 16/254
117.遠藤泰之、スタンダード薬学シリーズ 化学系薬学 II ターゲット分子の合成と生体分子・医薬品の化学（日本薬学会編）東京化学同人（東京）2005, p184-190, 7/240
118.遠藤泰之「創薬科学 生体構成分子から見た医薬品」（石橋弘行編）
廣川書店（東京） 2004, p1-14, p37-54, p88-98, 43/192
119.遠藤泰之、スタンダード薬学シリーズ 化学系薬学 I 化学物質の性質と反応（日本薬学会編）東京化学同人（東京）2004, p216-220, 5/ 327
120.遠藤泰之、スタンダード薬学シリーズ 医薬品の開発と生産（日本薬学会編）
東京化学同人（東京）2004, p81-90, 10/ 212